ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,620 | -100.0% | 8,400,000 | -50.9% | 0.01% | -57.1% |
| Q3 2022 | $9,629,000 | +1.7% | 17,100,000 | 0.0% | 0.01% | +7.7% |
| Q2 2022 | $9,469,000 | -3.8% | 17,100,000 | -10.5% | 0.01% | +18.2% |
| Q1 2022 | $9,848,000 | -23.2% | 19,100,000 | -21.4% | 0.01% | -21.4% |
| Q4 2021 | $12,818,000 | – | 24,300,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 18,764 | $9,907,000 | 0.77% |
| Pentwater Capital Management LP | 46,411,000 | $24,770,000 | 0.27% |
| WHITEBOX ADVISORS LLC | 22,500,000 | $11,756,000 | 0.24% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $10,993,000 | 0.23% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,590,000 | $9,286,000 | 0.20% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 24,000,000 | $12,540,000 | 0.18% |
| BlueCrest Capital Management Ltd | 7,000,000 | $3,705,000 | 0.12% |
| DCF Advisers, LLC | 400,000 | $211,000 | 0.09% |
| Walleye Capital LLC | 5,000 | $2,638,000 | 0.08% |
| INGALLS & SNYDER LLC | 883,000 | $461,000 | 0.02% |